LEF1 and cancer: Recently, Huang’s group (Shao et al., 2021) reported a similar study in which they demonstrated that highly cancer-related TF, lymphoid enhancer-binding factor 1 (LEF1), was efficiently degraded by O’PROTACs 29 (DC50 = 25 nM) (Figure 9C).